Journal Menu
► ▼ Journal Menu-
- Bioengineering Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
6 November 2025
MDPI Launches the Michele Parrinello Award for Pioneering Contributions in Computational Physical Science
MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.
The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.
About Professor Michele Parrinello
"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”
——Professor Michele Parrinello
![]() |
Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies. |
For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.
Award Committee
![]() |
The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process. The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award. |
"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."
——Professor Xin-Gao Gong
The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.
About the MDPI Sustainability Foundation and MDPI Awards 
The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields.
In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.
Find more information on awards here.
9 February 2026
Acknowledgment to the Reviewers of Bioengineering in 2025
The editorial office of Bioengineering would like to extend its sincere gratitude to all reviewers who contributed to the improvement of the journal quality by providing their expert opinion and evaluation of the submitted research.
We appreciate that thorough peer review demands considerable time and intellectual investment from our reviewers. In 2025, Bioengineering received 7348 review reports from contributors across 88 countries and territories, demonstrating the breadth of international expertise and scholarly engagement that has strengthened our publication standards.
The reviewers who agreed to have their names published this year are listed below in alphabetical order by first name. The editorial team acknowledges with gratitude all reviewers, named and anonymous alike, for their vital role in maintaining the scholarly standards of Bioengineering.
| A. A. Abd El-Aziz | Gilbert Lim | Nicoletta Cera |
| Abdelouahab Moussaoui | Giorgia Fiori | Nihal Olcay Dogan |
| Abdolreza Jamilian | Giorgio Perino | Nikolaos Zavras |
| Abdul Ahad | Giovanni Di Domenico | Nikolay Borisov |
| Abdul Rahaman Wahab Sait | Giovanni Diraco | Nitin Goyal |
| Abdulnaser M. Alshoaibi | Giovanni Ettore Gigante | Nitin Sampat Kamble |
| Abdur Rasool | Giulio Distefano | Niya Mileva |
| Abhijeet Anand | Giuseppe Gallo | Noor Kamal Al-Qazzaz |
| Abhilash Pati | Giuseppe Murdaca | Noura Ahmed |
| Abraham Abbey Paul | Giuseppe Stirparo | Octavio Andrés González-Estrada |
| Achanta Sampath Dakshina Murthy | Gonçalo Dias | Ognjen Arandjelovic |
| Adam Husein | Gopal Narayan Srivastava | Oleg G. Morozov |
| Addisson Salazar | Grzegorz Kalisz | Oleh Berezsky |
| Adel Elamri | Guglielmo Mantica | Oleksandr Barmak |
| Adem Ozcelik | Guilherme Sousa Bastos | Olga Gordeeva |
| Adil Asghar | Gulzar Mehmood | Olga Kamanina |
| Adnan Mohsin Abdulazeez | Guoqing Zhang | Olga Kudryashova |
| Adrian Lozano Alcañiz | Gurpreet Singh | Olga S. Zueva |
| Adriana Alexandru | Gururaj Kudur Jayaprakash | Olga V. Anatskaya |
| Adriano Cavalcanti | Gustavo Fernandes | Omar Trabelsi |
| Agnès Drochon | H. Eivaz Mohammadloo | Onur Basci |
| Ahila S. C. | H. M. K. K. M. B. Herath | Onur Can Kalay |
| Ahmed Abass | Hadi Khorshidi | Osamu Yamamoto |
| Ahmed Al Marouf | Hadi Tabesh | Oscar Arias-Carrión |
| Ahmed Al-Mukhtar | Halil Şenol | Oskar Sachenkov |
| Ahmed El-Fiqi | Hamed Hatami-Marbini | Osman Tunç |
| Ahmed G. Gad | Hamed Nozari | Ovidiu Mitu |
| Ahmed Mohamed Fahmy Yousef | Hamid Mukhtar | P. Ravi Reddy |
| Ahmet Cagdas Seckin | Hamid Reza Bakhsheshi-Rad | Padmanabhan Mahadevan |
| Ahmet Saygılı | Hamidreza Barnamehei | Panagiotis Mallis |
| Ajay Kumar Sahi | Hammad Ashraf Ganatra | Pankaj Kumar Jain |
| Akinori Kuzuya | Han Chao Chang | Pankaj Nandkishore Maheshwari |
| Akshaya Tatke | Hana Mackova | Paola Matarrese |
| Albérico Travassos Rosário | Hang Yang | Paolo Pagliuca |
| Albert Rizvanov | Haotian Cha | Patrícia Batista |
| Alberto Gómez-Mármol | Harikumar Rajaguru | Patrick Clemens |
| Alberto Isaac Perez Sanpablo | Hartmut F. Witte | Pattanasin Areeudomwong |
| Alberto Olmo | Hassan Al-Karagoly | Paul D. Mcgeoch |
| Alberto Souza Sá Filho | Hassan Harb | Paul Tucan |
| Alejandro Castro-Alvarez | Hassan Raza | Paula Maria Cordeiro Dores Rodrigues Peixe |
| Aleksander Mendyk | Hehua Ye | Pavel Makarevich |
| Aleksandr Rakhmangulov | Hemang Jani | Payal Ganguly |
| Aleksandr Romanov | Henrico Badaoui Strazzi-Sahyon | Pedro Esbrit |
| Aleksandr Sinitca | Hiam Alquran | Pedro Martins |
| Alesandr Krasnov | Hilario Gómez-Moreno | Pejman Goudarzi |
| Alessandra Scotto di Freca | Hisao Haniu | Pellegrino La Manna |
| Alessandro Giuliani | Hitoshi Tonomura | Perrey Stephane |
| Alessandro Messina | Hoda Hammad | Petar Ozretić |
| Alexander B. Konovalov | Hongtao Liu | Peter Kokol |
| Alexander Churyumov | Hossam Donya | Peter Rogelj |
| Alexander E. Berezin | Hossam Hawash | Petia Koprinkova-Hristova |
| Alexander Egorov | Houwei Zhu | Philip Thomas Moore |
| Alexander Gorodkov | Hsin-Yuan Chen | Pier Nicola Sergi |
| Alexander I. Titkov | Huamin Chen | Pierre-Simon Jouk |
| Alexander M. Demin | Huanjie Tao | Pilar Herrero-Martín |
| Alexander Meigal | Hugo Rositi | Pingfan Hu |
| Alexander Moskalensky | Husam Qanash | Piotr Sobolewski |
| Alexander Savostyanov | Hüseyin Bozkurt | Piyush Pradeep Mehta |
| Alexander Syuy | Huseyin Enes Salman | Pooja Sharma |
| Alexander V. Zakharov | Hüseyin Üzen | Po-Wen Chen |
| Alexander Yakunin | Hyun Jin Shin | Prabhu Sethuramalingam |
| Alexander Zhgun | Hyunsu Lee | Pradeepraj Durairaj |
| Alexandre Golub | Igor Ashurko | Prajoy Podder |
| Alexandru Corlateanu | Igor Belenichev | Prakash Rewatkar |
| Alexandru Dan Costache | Igor Dmitrievich Zlotnikov | Prakash Sojitra |
| Alexey Chubarov | Ildiko Szanto | Pranjyan Dash |
| Alexey Nikulin | İlknur Ak | Pravin Hivare |
| Alexey Yuri Smolin | Ilya D. Klabukov | Preeta Sharan |
| Ali Abu-Bakr | Iman Janghorban Esfahani | Preeti Kush |
| Ali Athar | Iman Qays Abduljaleel | Prince Jain |
| Ali Majeed Mahmood | Indrajeet Kumar | Przemysław Kasiak |
| Ali Mohammadi | Indranil Saha | Przemysław Podulka |
| Ali Rizwan | Inna Solyanikova | Purna Prakash Kasaraneni |
| Alina Pyka-Pająk | Innokentii Vishnyakov | Qi Shao |
| Alisa Domnina | In-Woong Um | Qiang Jiang |
| Alisa Pautova | Ioan Susnea | Qingyang Liu |
| Allan John Rada Barcena | Ioannis Tsoulos | Qiuyun Yin |
| Amarjitsing Rajput | Ioannis Vardiambasis | Radu Andrei Moga |
| Amin Naemi | Irena Ilic | Ragaa A. Hamouda |
| Amin Orash Mahmoudsalehi | Irena Jekova | Ragurethinam Shanmugam |
| Amir Javadpour | Irene Ottaviani | Raheel Muzzammel |
| Amir Khan | Irina Nakashidze | Rahul K. Kher |
| Amit Agrawal | Irina Valerievna Pronina | Raja Das |
| Amit Kumar Nayak | Ishtiaq Hussain | Rajagopal Maheswar |
| Amjad J. Humaidi | Ismail Bogrekci | Rajasekhar Nuvvusetty |
| Amr A. Arafat | Ismail Taha Ahmed | Ramalingam Manikandan |
| Ana Paula Gomes | I-Ta Lee | Ramazan Kursun |
| Ana Sanchez-Cano | Ivan A. Blokhin | Ramkumar Sivasakthivel |
| Anam Ahsan | Ivan A. Parinov | Ratko Pavlović |
| Anamaria Bechir | Ivan Corazza | Ravichandran Kollarigowda |
| Anand Swaminathan | Ivan Gustavo Masselli dos Reis | Raza Hasan |
| Anandharaj Marimuthu | Ivan Miguel Pires | Recep Dokuyucu |
| Anas Bilal | Ivan Mikheev | Redha Ali |
| Anastasios Apostolos | Ivan Miskulin | Reetesh Kumar |
| Anastasiya Runnova | Ivan Semenkov | Regina M. Islamova |
| Anastasiya Solovieva | Ivan V. Semenyuta | Renan Falcioni |
| Andre Luiz Ferreira Costa | Ivan Yu. Skvortsov | Renars Erts |
| Andrea Spitaleri | Ivaylo Dimitrov | Renato Racelis Maaliw III |
| Andrea Tacchino | Jadwiga Laska | Renjith V. Ravi |
| Andreas Brachner | Jakub Kufel | Reza Bazargan-Lari |
| Andrei A. Deviatkin | Jakub Szabelski | Rezaul Haque |
| Andrei Khlebnikov | James C. L. Chow | Riccardo Bruno Budai |
| Andres Blanco Ortega | James Chung Wai Cheung | Rim Bourgi |
| Andres Fernando Barajas-Solano | Janet H. H Southerland | Rita Chiaramonte |
| Andrew M. Lane | Janusz Strychalski | Robert Vianello |
| Andrew Petto | Jarosław Zubrzycki | Roberto Milazzotto |
| Andrey K. Gorshenin | Jason Fogler | Rocco De Vitis |
| Andrey Kuskov | Jason T. Smith | Rodrigo França |
| Andrey Romanenko | Javad Esmaeili | Rodrigo Galo |
| Andrey Tikhonov | Jayachandran Jayakumar | Rogerio Leone Buchaim |
| Andrey Zamyatnin | Jayanta Kumar Patra | Roseline Oluwaseun Ogundokun |
| Andrii Sverstiuk | Jefferson Ricardo Pereira | Rosella Cataldo |
| Andrii V. Kondratiev | Jia-Lang Xu | Roslyn Watson Livingstone |
| Andrzej Kasperski | Jian Wang | Rubén Arroyo Fernández |
| Aneta Ostróżka-Cieślik | Jianhua Wu | Rui Vitorino |
| Ángel Luis García-Otín | Jianing Xi | Ruihang Zhang |
| Angela Dell’Aversano | Jianzhao Qi | Ru-Lan Hsieh |
| Angelos K. Sikalidis | Jianzhong Hao | Ruslan Gibadullin |
| Anibal Alviz-Meza | Jiawei Xiong | Ruth Mackay |
| Aniruddha Bhattacharjya | Jie Zhang | S M Sohel Rana |
| Anish Shivaram | Jimin Lee | Saad Arif |
| Anmar Salih | Jinduo Liu | Sabatina Criscuolo |
| Anna Kharkova | Jing Selena He | Sachin Kumar |
| Anna Kosyreva | Jingtao Zhong | Sadik Kamel Gharghan |
| Anna Maria Grzywacz | Jinjun Xia | Sahbi Chaibi |
| Anna Temraleeva | Jithin Vishnu | Said El-Ashker |
| Anton R. Kiselev | Jiu Deng | Saima Noreen |
| Anton Zvonarev | Jiyoung Park | Sajjad Ahmad |
| Antonio Albuquerque | Joanna Romanek | Saleh Albahli |
| Antonio Borzelli | Joao da Silva Pereira | Samir Benbelkacem |
| Antonio Cicchella | João Paulo Saraiva Santos | Samir Kumar Bandyopadhyay |
| Antonio Córdoba-Fernández | Johannes Koren | Samira Farjaminejad |
| Antreas Kantaros | John Ayeelyan | Samit Kumar Ghosh |
| Anwar Ali Yahya | John Harvey Santos | Sandip B. Jadhav |
| Anwar Noman | John S. Mitchell | Sandor Bernad |
| An-Yi Chang | Johnson Retnaraj Samuel Selvan Christyraj | Sándor Beszédes |
| Ao Zhang | Jonas Michel Wolf | Sandra Vilas Boas Jardim |
| Apostolos Korlos | Jong-Eun Kim | Sanguk Son |
| Arlinda Luzi | José Alves | Sara Baldassari |
| Arsalan Ahmed | Jose Anand | Sara Metwally |
| Arshad Sher | José Luiz Rybarczyk-Filho | Sara Pimenta |
| Artem D. Rogachev | José Ricardo Cárdenas | Sara Valvez |
| Artem Obukhov | Jose Simoes | Sargol Mazraedoost |
| Artem Rubinstein | Josipa Kern | Saša Ćuković |
| Arulmurugan Ramu | Juan Bagó | Saswat Choudhury |
| Arunee Promsri | Juana Mayo Nuñez | Saturnino Marco Lupi |
| Arvind Mukundan | Juliusz Huber | Satya Kiran Koya |
| Ashish Dhayani | Jung-Tae Lee | Saverio Cosola |
| Ashkan Safari | Junxiang Chen | Seongjin Lim |
| Ashutosh Pandey | Jyotindra Narayan | Seppo Ahlfors |
| Assunta Pozzuoli | Kadhim K. Resan | Seren Başaran |
| Athanasios A. Panagiotopoulos | Kamal Sharma | Sergei Gennadevich Gaidin |
| Austin Bow | Kamalesh Chakravarty | Sergei Grishin |
| Awiruth Klaisiri | Kamil Dimililer | Sergey Gataullin |
| Aydin Bordbar-Khiabani | Kamil Gareev | Sergey Lytaev |
| Aydin Eresen | Kamil Nelke | Sergey N. Kolomeichuk |
| Azadeh Kiani-Sarkaleh | Kamran Iqbal | Sergey Sedykh |
| Azat Gabdulkhakov | Kanamat Efendiev | Sergey Simakov |
| Aziz Aksoy | Kandala N. V. P. S. Rajesh | Sergii Babichev |
| Azza H. Mohamed | Karel Allegaert | Sergio M. Navarro |
| Baklouti Souha | Karin Verspoor | Seshathiri Dhanasekaran |
| Balaji Dhandapani | Katarina Baralić | Seung-Myoung Son |
| Barbara Lapinska | Katsuhiko Oda | Seweryn Lipiński |
| Basel Mahafzah | Kaya Kuru | Seyed Borhan Mousavi |
| Basheer Abdullah Marzoog | Keigi Fujiwara | Shadfar Davoodi |
| Basilio Pueo | Kelvin Wong | Shahrokh Hatefi |
| Basilio Vescio | Kenneth Moser | Shahzad Ashraf |
| Baudolino Mussa | Kenneth R. Foster | Shaode Yu |
| Beat Goepfert | Kenneth Y. T. Lim | Shaoxing Dai |
| Bekir Dizdaroglu | Khadija El Aoufy | Shara W. Y. Lee |
| Berthold Rutz | Khaled A. Metwally | Sharmistha Roy |
| Bhupendra G. Prajapati | Khursheed Ahmad | Shayma Thyab Gddoa Al-Sahlany |
| Bhupinder Kumar | Kinde Anlay Fante | Shengzheng Kang |
| Biao Wang | Kira E. Vostrikova | Sherine Nagy Saleh |
| Biswaranjan Acharya | Kishore Debnath | Shihori Tanabe |
| Björn Friedrich | Klaus Casaro Saturnino | Shiva Shankar Reddy |
| Boddapati Taraka Phani Madhav | Koji Ichihara | Shumao Xu |
| Bogdan Andrei Suciu | Konstantin Kozlov | Shweta Tripathi |
| Bogdan Ene-Iordache | Konstantine Nadaraia | Silvia De Miguel Bilbao |
| Boguslaw Szczupak | Koray Açıcı | Simone Brogi |
| Bohua Zhang | Krishanu Ray | Siqi Chen |
| Boonlert Kukiattrakoon | Kristina Daunoravičienė | Siu Shing Man |
| Caglar Uyulan | Krzysztof Skrzypkowski | Siyamak Safapour |
| Carlos Alberto Jurado | Krzysztof Wołk | Skylar Holmes |
| Carlos Eric Galván-Tejada | Kubilay Gürünlüoğlu | Sofia Morozova |
| Carmen Concerto | Kuppusamy Pothanaicker | Somenath Chakraborty |
| Carsten Behn | Lambert Spaanenburg | Somnath Maji |
| Časlav Livada | Lan Lin | Sónia M. Rodrigues Oliveira |
| Catalin Pruncu | Laszlo Balkay | Søren Baarsgaard Hansen |
| Ce Liang | Laura C. J. Pereira | Sorin Marian Mârza |
| Cemil Colak | Leandro José Rodrigues Machado | Stan Lipovetsky |
| Cesar Augusto Roque-Borda | Leandros Stefanopoulos | Stanislav Dadelo |
| César Millán-Pacheco | Lei Zhuang | Stanislav O. Rogachev |
| Chandrakanta Mahanty | Lenka Lhotska | Stefan Weger |
| Chao Zhang | Leonard Ionut Atanase | Stefano Panareo |
| Charlotte H. Edinboro | Leonard Whye Kit Lim | Stoyanka Atanasova Nikolova |
| Chen Ling | Leonardo Bianchi | Su Yan |
| Chen-Chiung Hsieh | Leonel Paredes-Madrid | Subba Reddy Alla |
| Chenghao Chen | Leszek Szalewski | Subramanya G. Nayak |
| Chengle Zhou | Liang Tong | Subrata Chandra Das |
| Chenyu Huang | Lin Meng | Sudarsu V. Ramanaiah |
| Cheonshik Kim | Lingfeng Xu | Sudeep Sharma |
| Chethan Kn | Linping Zhao | Sudi Patel |
| Chetna Jadala | Lisa Kathleen Ryan | Sukhdev Roy |
| Chiagoziem Chima Ukwuoma | Liton Devanth | Sulagna Sanyal |
| Chih-Kun Hsiao | Liu Yang | Suleyman I. Allakhverdiev |
| Chih-Wei Zeng | Liudmila Gerasimova-Meigal | Suman Basak |
| Chin-Shiuh Shieh | Liuzhi Hao | Sumanth Ratna Kandavalli |
| Chitaranjan Mahapatra | Liviu Duta | Sumbul Hafeez |
| Christian Apel | Long Meng | Sumedha Nitin Prabhu |
| Christian Ralf Gernhardt | Longbing Ling | Sundar Ramalingam |
| Christie Ying Kei Lung | Lorenzo Putzu | Sung-Lang Chen |
| Christina Oetzmann von Sochaczewski | Lothar Koch | Suparerk Janjarasjitt |
| Christos Orovas | Luca Catalina | Surej Mouli |
| Chuan Li | Luca Martini | Sushil Lathwal |
| Chun Kit Kit Choi | Luca Negosanti | Suvitesh Luthra |
| Clara Martínez Pérez | Luca Paolo Ardigò | Syed Umar Amin |
| Colin K Drummond | Lucio Caprioli | Syeda Aaliya Shehzadi |
| Congjie Wei | Luigi Bibbò | Tadeusz Ambroży |
| Constantinos M. Koutsojannis | Luiz Henrique Palucci Vieira | Tadeusz Hryniewicz |
| Cosmin Mihai Vesa | Lukasz Jelen | Tahir Cetin Akinci |
| Cristian Ichim | Lukasz Scislo | Tahir Yagdi |
| Cristian Randieri | Lyudmila V. Bel’skaya | Tahir Yusuf Noorani |
| Cristian Rotariu | M. Mujiya Ulkhaq | Takashi Matsumoto |
| Cyrus Motamed | M. Ramesh | Takashi Okiji |
| Daniel B. Hier | Madhav Rao | Tamás Kovács-Öller |
| Daniel Yarosh | Madhusudan B. Kulkarni | Tao Ma |
| Daniela Santucci | Madjid Soltani | Tarek Dayyoub |
| Daniele Della Latta | Maheshwaran Selvarasu | Tarik Kivrak |
| Dan-Marius Dobrea | Mahmood Bahramizadeh | Tariq Ali |
| Dario Donno | Majid Monajjemi | Tatiana V. Rakitina |
| David A. Gabrielyan | Malaya Kumar Nath | Tatiana V. Safronova |
| David Brooks | Malinee Sriariyanun | Tatsuya Sato |
| David I. Leavesley | Man-Fai Leung | Terence Yew Chin Tan |
| Davor Horvatic | Manish Kumar Gupta, India | Thi Sinh Vo |
| Dayu Hu | Manish Kumar Gupta, USA | Thomas Eger |
| De Rosal Ignatius Moses Setiadi | Manjit Panigrahi | Thomas Pincez |
| Deepak Berwal | Manlio Tassieri | Tian Zhao |
| Deepanjan Ghosh | Mansoor Hayat | Tim Morris |
| Delaram J. Ghadimi | Manuel F. M. Costa | Ting Li |
| Denis Butusov | Manuel J. Lis | Ting-Yu Lu |
| Denis Losik | Mara Carsote | Tomas Ruzgas |
| Deokho Lee | Maram Bani Younes | Tomasz Marciniak |
| Devesh U. Kapoor | Marcel F. Kunrath | Tomokazu Hattori |
| Dhananjay Singh | Marcin Kołodziej | Tomotaka Shimura |
| Dhiraj D. Bhatia | Marcin Zieliński | Toshiyuki Kawai |
| Dhirendra Prasad Yadav | Maria Elisabete Teixeira Silva | Tri Harsono |
| Diego Primavera | Maria G. Chernysheva | Tudor Sorin Pop |
| Diego Sangiorgi | Maria João Calheiros-Lobo | Turkan Kopac |
| Dignesh Khunt | Maria Kuyukina | Tzu-Yu Peng |
| Dinata Roy | Maria Pia Ferraz | Uldis Berkis |
| Dinesh Nyavanandi | Mariana Floria | Ulyana S. Zubairova |
| Dipak Kumar Sahoo | Mariantonia Braile | Valentin Oleynikov |
| Dmitry Namiot | Mario Taba, Jr. | Valentino Vellone |
| Dorota Chełminiak-Dudkiewicz | Mario Zuccarello | Valeriya R. Samygina |
| Dror Malka | Marios Spanakis | Vasileios Papageorgiou |
| Durairaj Siva | Marius Bumbac | Vasileios Vazgiourakis |
| Dzmitry G. Shcharbin | Mark Eiteman | Vassilis Athanasiadis |
| E. I. Abdul Sathar | Markus Storr | Vassilis Martiadis |
| Ebrahim Mohammed Senan | Martin Branko Popevic | Vasudha Srivastava |
| Ecir Uğur Küçüksille | Martina Schiavello | Vedat Tümen |
| Edvard Ehler | Martino Giaquinto | Vera A. Alferova |
| Edward Vitkin | Matteo Armillotta | Verena Charwat |
| Egor Olegovich Osidak | Matteo Nioi | Vessela Krasteva |
| Ehsan Vafa | Matthew B. Rhudy | Vicente Javier Clemente-Suárez |
| Eisuke Hanada | Maxim Polyakov | Victor Díaz-Flores García |
| Ekaterina Dinastiia | Mehmet Ali Balci | Victor I. Sevastianov |
| Ekaterina Kopets | Mehmet Kaya | Viet Anh Nguyen |
| Ekaterina Naumenko | Mehmet Topuz | Vincent Omollo Nyangaresi |
| Eleftherios Touloupakis | Mehmet Zeki Konyar | Vincent Peter C. Magboo |
| Elena Artioli | Meng Li | Vincenzo Alfano |
| Elena Solovyeva | Michael Gray | Vincenzo Grassia |
| Elena V. Tchetina | Michael Samaan | Visnja Katic |
| Elena Verdú | Michael V. Fedewa | Viswas Raja Solomon |
| Eleni Mavrogonatou | Michaela Cellina | Vladimir Kenis |
| Elisabetta Sieni | Michail Kalogiannakis | Vladimir Tikhonov |
| Elissavet Anestiadou | Michał Strzelecki | Vladimir Tsurkov |
| Elnaz Pashaei | Michele Paolantonio | Vladimir Yusupov |
| Emi Yuda | Michele Schiano di Visconte | Vladislav V. Fomenko |
| Emiliano Tesoro-Cruz | Miguel A. Castro Villamor | Vrinda Gote |
| Emmanouil Ioannis Kapetanakis | Miguel Fernandes | Vsevolod Lyakhovetskii |
| Emyr Wyn Benbow | Mihaela Pertea | Vyacheslav Arlyapov |
| Enita Nakas | Mihail Mitov | Wafa Baccouch |
| Enoch Mensah | Mikhail A. Tashkinov | Wasifa Naushad |
| Enrico Di Bella | Mikhail N. Efimov | Wei Zhang |
| Erfan Taatizadeh | Mikhail Ponomarenko | Weiqiang Hong |
| Ergun Alperay Tarim | Milan Toma | Weiwei Jiang |
| Eric di Luccio | Miloš Vujisić | Wen Shi |
| Erinija Pranckeviciene | Mina Shahriari Khalaji | Wen-Pin Hu |
| Ernesto Moya-Albor | Ming Lu | Wen-Wei Robert Hsu |
| Essam Rashed | Ming Yan | Wenxin Niu |
| Esther Juliana Ocola | Minhyeok Lee | Wiktor Stopyra |
| Eugenio Martelli | Mithun Santra | Wissem Dhahbi |
| Eunice Carrilho | Moezalislam Ezzat Faris | Wojciech Czekała |
| Evandro Watanabe | Mohamad Shahgholi | Wojciech Zabierowski |
| Evangelia Vouvoudi | Mohamed Hany | Xenophon Zabulis |
| Everton Freitas de Morais | Mohamed K. Elhadad | Xianzhi Wang |
| Evgenia Korzhikova-Vlakh | Mohamed S. A. Darwish | Xiao Jian Tan |
| Evgenia Sitnikova | Mohammad Ghorbani | Xiaoqi Zhang |
| Evgeny Nikulchev | Mohammad Mofatteh | Xin Bi |
| Evgeny V. Morozov | Mohammad Naderan | Yafeng Liu |
| Fabio Zaina | Mohammad Qneibi | Yan Yang |
| Fabrizia d’Apuzzo | Mohammad Reza Raveshi | Yanhong Peng |
| Fahmi Fahmi | Mohammad Shokouhifar | Yanlong Ji |
| Fahmi Zairi | Mohammad Younis Hajeer | Yaoxiang Li |
| Faisal Maqbool Zahid | Mohammed A. M. Abdullah | Yelena Valentinovna Likhoshway |
| Fariba Malekpour Galogahi | Mohammed Al-Shomrani | Yıldıray Yalman |
| Fatma Latifoğlu | Mohammed Aslam | Ying Liu |
| Fedor Barkov | Mohammed Ramadan | Yixuan Feng |
| Fei Fan | Mohammed Sallah | Yong Wei Tiong |
| Fei Han | Mohammed Sayed | Yoshihiro Noda |
| Felix Blyakhman | Mohsen Shahrousvand | Yu-Chung Wei |
| Felix Javier Jiménez Jiménez | Mona Semalty | Yuhan Yang |
| Feng Yang | Monique J. J. Leys | Yunfeng Wu |
| Fengying Tang | Mostafa Shooshtari | Yung Hsiang Chen |
| Fernando Almeida | Mugahed A. Al-Antari | Yung-Kang Shen |
| Filippo Laganà | Muhammad Ali Butt | Yuri Efremov |
| Fiorenzo Moscatelli | Muhammad Farooq Siddique | Yuri Gordienko |
| Fırat Hardalaç | Muhammad Sardaraz | Yuriy L. Orlov |
| Flavio Bertini | Mukesh Kumar Nag | Yuto Uchida |
| Florin Filip | Murat Ucan | Zaffar Ahmed Shaikh |
| Fo Hu | Mustafa Berkan Bicer | Zainab T. Al-Sharify |
| Focke Ziemssen | Mustafa Busuladžić | Zdzisław Kinart |
| Francesca Angelone | Nadeem Javaid | Zenon Pogorelić |
| Francesco Baino | Nadezhda Todorova | Zhanguo Gao |
| Francesco Bianconi | Nafisa Gull | Zhanhong Du |
| Francesco Crenna | Najib Ben Aoun | Zhekai Hu |
| Francesco Stilo | Nalin Maniya | Zhen Xiao |
| Francis Zarb | Naonori Kawakubo | Zhengwei Huang |
| Francisco J. Perales | Narayanaswamy Venketasubramanian | Zhenli Lu |
| Frank Barnes | Naresh Kumar Mani | Zhibin Zhou |
| G. P. Ramesh | Narongchai Autsavapromporn | Zhidong Zhou |
| Gabriel Furtos | Nasir Uddin | Zhigong Wang |
| Gabriela Vochita | Natalia N. Rudenko | Zhiqiang Ma |
| Gabriele Maria Fortunato | Natallia Dubashynskaya | Zhiyuan Yang |
| Galina V. Kurlyandskaya | Natassa Pippa | Zicheng Deng |
| Gaurav Pandey | Natella Enukashvily | Žiga Gosar |
| Gayathri Thevi Selvarajah | Nathaniel Hafer | Zihan Yang |
| Gennadi Saiko | Nattawooti Sthitmatee | Zixin Wang |
| Georg Fischer | Nick Vordos | Zoe Valero-Ramon |
| George Karabatsos | Nicola Manocchio | Zulkif Tanriverdi |
| Georgios Iatrakis | Nicolai Panikov | |
| Ghaith Aloui | Nicoleta Anton |
2 February 2026
MDPI INSIGHTS: The CEO's Letter #31 - MDPI 30 Years, 500 Journals, UK Summit, Z-Forum Conference, APE
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

MDPI at 30: Three Decades of Open Science, Built Together
As we begin 2026, we approach a meaningful milestone in MDPI’s history: 30 years of advancing Open Science.
What began in 1996 as a small, researcher-driven initiative has grown into a global open-access publisher, supporting hundreds of journals, millions of researchers, and a shared belief that scientific knowledge should be openly available to all. Over these three decades, Open Access has moved from the margins to the mainstream, and MDPI has been proud to help shape that transformation.
To mark this anniversary year, we are pleased to share our MDPI 30th Anniversary logo.
The Anniversary logo is intentionally simple, confident, and enduring, designed to work across cultures, disciplines, and digital environments. It reflects both continuity and progress, honouring MDPI’s established identity while representing the company we are today. The green accent symbolizes our connection to the research communities we serve and the collaborative nature of Open Science itself.
Alongside the visual identity, we are also introducing our 30th Anniversary tagline:
30 Years of Open Science, Built Together.

This phrase captures what has always defined MDPI. Open Science is not the work of a single organization: it is a collective effort shaped by researchers, editors, reviewers, institutions, and the many teams who support the publishing process every day. MDPI’s role has been to provide the infrastructure and commitment that allow this collaboration to thrive.
Throughout 2026, we will mark this anniversary through regional events, global conversations, and editorial initiatives that reflect on MDPI’s evolution, its impact across disciplines, and the communities that make this work possible.
“Open Science is a collective effort”
Whether you have been part of MDPI’s journey for decades or are engaging with us for the first time this year, this milestone belongs to all of us. The past 30 years have shown what is possible when openness, trust, and collaboration are placed at the centre of scholarly communication.
As we look ahead, our focus remains clear: continuing to strengthen quality, integrity, and partnership – so that Open Science can keep moving forward, together.
Impactful Research

A Shared Milestone: MDPI’s Journal Portfolio Reaches 500 Titles
MDPI has reached an important milestone: our journal portfolio grew to more than 500 academic journals last year, spanning the fields of chemistry, engineering, biology, medicine, environmental sciences, the social sciences, and beyond.
The number itself is significant, but what matters more is what supports it: hundreds of scholarly communities that have chosen to collaborate, grow, and publish with MDPI.
From our beginnings nearly 30 years ago with a single Open Access journal (Molecules), MDPI has been guided by a simple aim: advancing Open Science. Reaching 500 journals is not an endpoint. It reflects the diversity of disciplines, ideas, and research cultures that now form part of our shared ecosystem.
Growth with Purpose
Every journal exists because a specific community believes there is a need for focus, visibility, and dialogue in a particular field. As our portfolio has expanded, so has our responsibility to ensure that scale is matched with strong editorial standards, robust research integrity practices, and meaningful academic leadership.
This milestone comes as we enter MDPI’s 30th anniversary year, a fitting moment to reflect on what scale in scholarly publishing truly requires: not only reach, but also dedicated long-term stewardship.
New Journals, New Communities
In December 2025 alone, MDPI welcomed eight newly launched journals and three journal transfers (details below), all of which published their inaugural issues by year-end.

Each of these journals is shaped by its Editors-in-Chief, Associate Editors, and Editorial Board Members, who define its scope, standards, and direction. We are grateful for the time, expertise, and commitment they bring to building these new communities.
Welcoming Transferred and Acquired Journals
We were pleased to publish the first MDPI issues of three recently transferred or acquired journals:
- Cardiovascular Medicine – advancing research on the prevention, diagnosis, and treatment of cardiovascular disease
- Germs – addressing infectious diseases through clinical, public health, and translational perspectives
- Romanian Journal of Preventive Medicine (RJPM) – supporting population health, early detection, and preventive care in collaboration with the Romanian Society of Preventive Medicine
Each of these journals brings an established identity and legacy. Our role is to support their continued development with the same editorial rigor, transparency, and Open Access principles that guide our broader portfolio.
A Collective Achievement
Reaching more than 500 journals is not the achievement of any single team or individual. It is the result of collaboration across the entire scholarly ecosystem. As such, I would like to thank our authors, reviewers, academic editors, and Editorial Board Members, as well as our colleagues across MDPI, who support these communities every day.
As we look ahead, we will continue to expand the breadth and depth of our publishing activities while remaining attentive to the evolving expectations of Open Science, research integrity, and responsible growth.
This milestone is a reminder that Open Access publishing is not only about making research available. It is about building platforms where knowledge can be shared, challenged, improved, and trusted, at scale, and with care.
Inside Research

MDPI UK Summit 2026 in Manchester (21–22 January)
On 21–22 January, we had the pleasure of hosting the MDPI UK Summit 2026 in Manchester. Over two days, we welcomed more than 20 Editors-in-Chief (EiC), Section Editors-in-Chief (SEiC), and Associate Editors for an open, in-depth conversations about how MDPI supports Open Science, editorial independence, and research standards across our journals.
What stood out most was not just the quality of the discussions, but the openness, curiosity, and mutual respect that shaped every session.
|
|
|
|
|
|
|
|
What We Covered
The programme was designed to give insight into how MDPI works behind the scenes and how different teams collaborate to support our journals and editors. Topics included:
- MDPI overview and the evolving Open Access market
- MDPI–UK collaboration and local engagement
- Editorial and peer-review processes
- Research integrity and publication ethics
- Institutional partnerships
- Indexing, journal development, and academic community engagement
Sessions were led by MDPI colleagues across editorial, research integrity, indexing, partnerships, and UK operations, showing how cross-functional our work truly is.
What We Heard
The feedback from editors was both encouraging and grounding:
- 92% rated the Summit Excellent (8% Good)
- 100% said their understanding of MDPI’s values, editorial processes, and local collaborations had significantly improved
- 69% attended primarily to stay informed about academic publishing and research integrity
- 85% felt fully heard and engaged
A few comments that stayed with me:
- “Today’s event truly gave me the opportunity to see the heart of MDPI UK.”
- “The summit was very informative – I really enjoyed seeing the behind-the-scenes operations.”
- “Keep being open to discussions and making editors feel part of the MDPI family.”
These reflections remind us that transparency, listening, and dialogue are not nice-to-haves: they are foundational to trust.
|
|
|
|
Looking Ahead
The UK Summit is one of more than 10 MDPI Summits we are organizing this year across North America, Europe, and APAC. Each one is an investment in relationships, shared understanding, and improvement.
Thank you to the MDPI UK team and supporting colleagues across departments who made this event possible. This was a positive step in strengthening our editorial engagement and kicking off a year of MDPI Summits.
Coming Together for Science

Recapping the Z-Forum 2026 Conference on Sustainability and Innovation (15–16 January 2026)
In January, MDPI supported and participated in the Z-Forum on Sustainability and Innovation, held across Zurich (ETH Zurich) and the city of Baden. With 96 participants and more than 30 speakers and panellists, the forum brought together leaders from government, academia, industry, and innovation ecosystems to explore how sustainability, Open Science, and innovation intersect in practice.
Why this mattered for MDPI
As a Swiss-based publisher with global reach, our investment in Z-Forum reflects a strategic intent: to anchor MDPI more deeply within Swiss research networks while contributing to national and international conversations on sustainability and innovation.
This was not only about visibility; it was also about relationship-building and long-term engagement with institutions shaping research policy and practice in Switzerland.
|
|
|
|
|
|
|
|
|
|
High-level participation and credibility
The forum was supported and sponsored by several key Swiss institutions, including:
- The Swiss National Science Foundation (SNSF) – Switzerland’s central research funding body
- ETH Zurich
- The University of Zurich
- The University of Basel
- Swiss Innovation Park Central
The sponsorship of SNSF lent the forum strong institutional credibility and signalled the relevance of the themes discussed, especially around sustainability, innovation frameworks, and responsible research practices.
|
|
|
Beyond the Room: Extending the Conversation
While attendance was intentionally focused to encourage dialogue, the forum’s reach extended well beyond the venue. Multiple LinkedIn posts before and during the event (e.g., Link 1, Link 2, Link 3, and more) built on the discussions and helped position MDPI as an active and credible contributor within Switzerland’s research and innovation landscape.
A Broader Strategic Signal
Z-Forum is part of a wider effort to:
- Build on MDPI’s Swiss institutional relationships
- Reinforce our leadership in Open Science and sustainability
- Engage proactively with funders, universities, and innovation bodies
- Ensure MDPI remains a visible and constructive partner in the ecosystems where research policy and practice are shaped
Thank you to our Conference team and everyone involved in supporting this event, both behind the scenes and on the ground. These moments of engagement may be small in scale, but they are foundational in impact.

Closing Thoughts

Reflections from the Academic Publishing in Europe Conference
During 13-14 January, I attended the Academic Publishing in Europe (APE) Conference in Berlin, a long-standing forum for discussing scholarly publishing and the deeper principles that support it.

MDPI was proud to be a Gold Sponsor of the 20th Anniversary of the APE conference, reflecting our continued commitment to supporting the scholarly community to engage in critical industry discussions.
This year’s program covered a range of topics, from AI and research integrity to policy, infrastructure, and trust, but one theme stood out clearly for me: academic freedom, and what it means to protect the conditions under which knowledge can be produced, evaluated, and shared responsibly.
Before turning to that, I would like to highlight the opening keynote by Carolin Sutton (CEO, STM), which helped set the tone for the conference.
An Independent Publishing Industry: The Case for Checks and Balances
In her opening remarks, Carolin focused on the importance of continually evolving systems of checks and balances, both operationally and at the marketplace level, to prevent any single actor from dominating knowledge production. Her framing emphasized shared responsibility across publishers, institutions, and research communities, rather than placing the burden on any one group.
As part of this, she revisited the work of sociologist Robert K. Merton, and his CUDOS norms of scientific ethos, first articulated in his 1942 work, The Normative Structure of Science.

Merton outlined four ideals that support healthy scientific systems:
- Communalism – knowledge as a public good
- Universalism – evaluation based on merit, not status or identity
- Disinterestedness – orientation toward truth over personal or financial gain
- Organized Skepticism – systematic, critical scrutiny of claims
While these are ideals, and not guarantees that are perfectly lived up to, they remain powerful reference points today for research systems and organizations as they aim to grow and scale.
It was interesting to see how closely these norms align with foundational principles of Open Access. For example, making research openly available supports communalism. Transparent peer review and editorial processes reinforce universalism and organized skepticism. Strong ethics frameworks and governance help counter conflicts of interest and support disinterestedness.
“Merton’s ideals remain powerful reference points today”
Safeguarding Research: Academic Freedom
Several of the conference sessions touched on the pressures faced by researchers, editors, and institutions: geopolitical tensions, online harassment, misinformation, reputational risk, shrinking resources, and politicized narratives around science.

“Integrity is not static. It must be actively maintained as systems grow.”
A particularly timely presentation came from Ilyas Saliba, who talked about academic freedom. His remarks resonated strongly and underlined the fact that safety in academia is not only physical or digital, but also intellectual.
Academic freedom means safeguarding the ability to ask difficult questions, challenge consensus, publish negative or unexpected results, and participate in scholarly debate without fear of undue personal, political, or commercial consequences. These discussions were a reminder that publishers play an important role in supporting the integrity, accessibility, and credibility of scholarly knowledge, particularly as researchers and institutions face mounting external pressures.
Looking Ahead
The discussions at APE reminded me that integrity is not static. It must be actively maintained as systems grow, expectations evolve, and pressures increase. This applies equally to research integrity, academic freedom, and the broader trust placed in scholarly communication.
I left APE encouraged by the openness of the dialogue and the willingness across publishers, institutions, and communities to engage with difficult questions rather than avoid them. Forums like this play a pivotal role in helping our industry pause, reflect, and recalibrate.
As MDPI continues to grow and as we enter our 30th anniversary, these conversations remind me of the core purpose of science: advancing knowledge for the benefit of society.
Chief Executive Officer
MDPI AG
29 January 2026
MDPI Reviewer Club Webinar 2026 | Engineering Session 2, 5 February 2026
At MDPI, we recognize that peer review is the foundation of scientific progress. The integrity, transparency, and quality of our journals depend on the careful evaluations provided by our reviewers. In 2024 alone, more than 215,000 reviewers contributed over 1.2 million reports to MDPI journals. This achievement reflects the strength of our community, and it is through the expertise and dedication of reviewers like you that scholarly communication continues to advance worldwide.
The MDPI Reviewer Club series was created to acknowledge this important role and to provide a vibrant forum for sharing experiences, exchanging best practices, and building meaningful connections across disciplines.
We are delighted to invite you to our upcoming webinar: “MDPI Reviewer Club Webinar 2026 | Engineering Session 2”.
This session is designed as a dedicated space for reviewers in the Engineering discipline to connect, exchange insights, and celebrate the vital role they play in advancing scholarly publishing.
With the consent of our speakers, presentations will be recorded and shared on MDPI platforms, accompanied by introductions and discussion threads to continue the exchange long after the event.
If you are not yet part of our reviewer community, we warmly invite you to apply to join us as a reviewer. For further details about reviewing with MDPI, please also visit our page here, where you will find information on reviewer responsibilities, ethics, and the peer review process.
We warmly welcome you to join us for this inspiring exchange at the MDPI Reviewer Club 2026 | Engineering Session 2.
Keywords: peer review; reviewer guidelines; reviewer experience; ethics in peer review
Date: 5 February 2026 | 2:00 p.m. CET | 9:00 p.m. CST Asia | 7:00 a.m. EDT
Webinar ID: 814 6288 4944
Website: https://sciforum.net/event/MRC2026-ES2
Register now for free!
|
Speaker |
Presentation Title |
Time in CET |
Time in CST (Asia) |
|
|
Introduction |
2:00–3:10 p.m. |
9:00–11:10 a.m. |
|
Dr. Giacomo Peruzzi |
Peer Review Between Judgment and Automation - Keeping it Human in the Age of AI |
5:10–5:30 p.m. |
11:10–11:30 a.m. |
|
Dr. Georgi Gary Rozenman
|
Rewiring Peer Review in the Age of Screenshots, Simulations, and AI Generated Synthetic Data |
5:30–5:50 p.m. |
11:30–11:50 a.m. |
|
|
Q&A Session |
6:10–6:30 p.m. |
12:10–12:30 p.m. |
|
|
Closing of Webinar |
6:30–6:35 p.m. |
12:30–12:35 p.m. |
After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.
Webinar Speakers:
- Dr. Giacomo Peruzzi, Department of Information Engineering, University of Padova, Italy;
- Dr. Georgi Gary Rozenman, Department of Mathematics, Massachusetts Institute of Technology, USA.
9 January 2026
MDPI’s Newly Launched Journals in December 2025
We have expanded our open access portfolio with eight new journals publishing their inaugural issues in December 2025, as well as three journal transfers. These additions span physical sciences, social sciences, arts and humanities, environmental and Earth sciences, medicine and pharmacology, and public health and healthcare. We extend our sincere thanks to the Editors-in-Chief, Associate Editors, and Editorial Board Members who are shaping these journals’ direction. All journals uphold strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.
Please feel free to browse and discover more about the new journals below.
|
New Journals |
Founding Editor-in-Chief(s) |
Journal Topics (Selected) |
|
|
Dr. Elisa Felicitas Arias, Université PSL, France |
atomic clocks; time and frequency metrology; GNSS systems; relativity and relativistic timekeeping; fundamental physics in space | |
|
|
Prof. Dr. José F.F. Mendes, University of Aveiro, Portugal |
complex systems; network science; nonlinear dynamics and chaotic behaviour; information theory and complexity; computational complexity | |
|
|
Prof. Dr. Roberto Morandotti, Institut National de la Recherche Scientifique—Énergie, Matériaux et Télécommunications (INRS), Canada |
light generation; light sources and applications; light control and measurement; human responses to light; lighting design | |
|
|
Prof. Dr. Savvas A. Chatzichristofis, Neapolis University Pafos, Cyprus |
generative AI and large language models in education; multimodal and embodied AI; personalization and adaptive systems; assessment, feedback, and academic integrity; learning analytics | |
|
|
Prof. Dr. Jon Andoni Duñabeitia, Universidad Nebrija, Spain |
cognitive psychology; cognitive neuroscience; psycholinguistics; applied linguistics; experimental psychology | |
|
|
Prof. Dr. Caiwu Fu, Wuhan University, China; Prof. Dr. Longxi Zhang, Peking University, China |
cultural practices; cultural theory; cultural policy; cultural heritage; transregional and transnational cultural flows| |
|
|
Dr. Ghassem R. Asrar, iCREST Environmental Education Foundation, USA |
biosphere interactions, processes, and sustainability; ecosystem science and dynamics; biodiversity conservation; global change and environmental adaptation; biogeochemical cycles | |
|
|
Dr. Giuseppe Mulè, University of Palermo, Italy |
cardiorenal syndromes; chronic heart failure and chronic kidney disease; cardiorenalmetabolic syndrome; hypertension and diabetes in relation to the abovementioned syndromes; diagnostic techniques | |
|
Transferred Journals |
Editor-in-Chief |
Journal Topics (Selected) |
|
|
Prof. Dr. Peter Matt, Lucerne Cantonal Hospital (LUKS), Switzerland |
cardiology; cardiovascular and aortic surgery; cardiovascular anatomy, physiology and pathophysiology; congenital heart disease and pediatric cardiology; cardiovascular regenerative and reparative medicine | |
|
|
Prof. Dr. Oana Săndulescu, Carol Davila University of Medicine and Pharmacy, Romania; National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Romania |
infectious diseases across clinical and public health domains; epidemiology of communicable diseases; clinical microbiology and applied virology; vaccinology and immunization; host–pathogen interactions and immunity | |
|
|
Dr. Roxana Elena Bohiltea, “Carol Davila” University of Medicine and Pharmacy, Romania |
public health; disease prevention; screening and early detection; lifestyle interventions and health education; digital and innovative prevention | |
We would like to thank everyone who has supported the development of open access publishing. If you would like to create more new journals, you are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com).
31 December 2025
MDPI INSIGHTS: The CEO's Letter #30 - Scaling with Integrity, Highly Cited Researchers, KEMÖ Consortium, Michele Parrinello, and Best PhD Thesis Awards
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

With colleagues at MDPI headquarters in Basel, representing the people behind our global growth and shared commitment to integrity.
Scaling with Integrity: A Year of Growth, Responsibility, and Trust
When I look back on 2025, one phrase seems to sum up the year: “Scaling with integrity.” That was our watchword for 2025, and it will remain so as we move forward in to 2026.
Our journal portfolio continued to grow in 2025, reflecting the trust of a widening proportion of the scholarly community.
Today, MDPI has 355 journals indexed in Scopus and 330 in Web of Science – a testimonial to the scale at which our journals meet established external quality criteria. During the year, 45 of our journals were newly accepted into Scopus and 29 into Web of Science (this excludes transferred journals to our portfolio that were already indexed), following rigorous, independent evaluation by the world’s leading indexing bodies
Meeting external quality benchmarks
These results underline the fact that scaling responsibly is not only about expanding our catalogue, but also about meeting external quality benchmarks consistently, transparently, and at scale. Our indexing performance remains one of the strongest independent validations of MDPI’s commitment to rigor, trust, and long-term sustainability.
Over the course of 2025, we made targeted investments to ensure that the integrity of our editorial process scaled to keep pace with our growth. We strengthened our editorial governance by doubling down on our dedicated Publication Ethics department, appointing a Head of Ethics, and expanding our research integrity team by the addition of new specialists plus the creation of embedded editorial ethics roles across key journals. We also introduced new internal ethics guidelines, pre-review integrity checks, and monitoring dashboards to help teams identify potential issues and apply consistent standards across our portfolio.
Besides investing in systems and tools, we of course also invested heavily in our people and culture, delivering organisation-wide training on topics such as image integrity, AI use in publishing, and ethical oversight, while actively engaging with the wider publishing community through COPE and STM forums.
All these efforts reflect a simple principle: growth only matters if it is matched by rigor, responsibility, and trust.
Technology and AI: Supporting the editorial decision-making process
At MDPI, AI is designed to assist, not replace, editorial decision-making. It is one element in a broader system that combines people, technology, and processes to support scale responsibly.
In 2025, we continued to invest heavily in technology that supports quality rather than shortcuts. Our AI team doubled in size, ensuring that increased automation goes hand-in-hand with expertise and oversight. Proprietary AI tools such as Scholar Finder have significantly improved the precision of reviewer matching, while Ethicality has been widely adopted across editorial workflows to identify contextual signals, such as scope alignment and citation behaviour, so that human judgment can be applied where it matters most.
Partnerships: Institutional Open Access Program (IOAP) agreements and Societies
Our recent growth is also reflected in the strength of our partnerships. In 2025, we entered into more than 150 new IOAP agreements, bringing our total to 975 active agreements worldwide. This activity included the signing of our first-ever consortium agreements in North America, renewals of all major national consortia in the UK, Switzerland, Sweden, Norway, Austria, and Croatia, and the conclusion of several flat-fee agreements. At the same time, we concluded a total of 30 agreements, encompassing 24 new Society affiliations, four strategic publishing partnerships, and two journal acquisitions.
In 2025, we opened MDPI USA in Philadelphia – our latest global office, which complements our Toronto office in representing North America. MDPI USA is responsible for accelerating Open Access in the US through ongoing support of our scholars and for expanding our institutional and society partnerships.
On the other side of the globe, meanwhile, we signed an IOAP agreement in India, allowing researchers discounted Article Processing Charges (APCs), streamlined APC management for universities, and visibility into submissions, supporting India’s push for wider Open Access by offering flexible models and helping institutions meet national mandates such as Plan S.
Sustainability, sponsorships and awards
We continued to expand our sustainability efforts during 2025, hosting the 11th World Sustainability Forum, awarding CHF 125,000 in sustainability-related funding, and launching the Z-Forum on Sustainability and Innovation conference, which will officially take place in January 2026.
We also saw a record year for conference sponsorships and awards (while establishing new awards such as the Michele Parrinello Award), recognising scholars across disciplines and reinforcing our commitment to supporting the global research community at every stage of the academic journey.
Deepening our relationships
In 2025, I had the opportunity to travel more widely than ever before on MDPI business, meeting many of our stakeholders face to face and relishing the opportunity to gain a deeper understanding of their science communication needs. It was also excellent to visit a large number of MDPI offices and witness the commitment and service orientation of so many of our colleagues around the world. I shall resume my itinerary in the new year, and I look forward to many more such interactions.
Looking ahead to 2026, we will be celebrating a very significant milestone: 30 years of MDPI. From our foundation as a single Open Access journal in 1996 to the global publishing organisation we are today, our mission has remained consistent: advancing Open Access through rigorous and trustworthy scientific communication.
I would like to take this opportunity to thank all our stakeholders – authors, Editors-in-Chief, Editorial Board members, and reviewers – who have placed their trust in us during 2025. On behalf of the entire MDPI team, I look forward to deepening our relationships yet further in 2026 and celebrating 30 Years of Open Science at MDPI, something we’ve built together.

Basel, Switzerland, where MDPI was founded in 1996.
Impactful Research

621 MDPI Editors Named Highly Cited Researchers in 2025
I am pleased to share an important milestone for our editorial community and for MDPI. In late November, Clarivate announced the 2025 Highly Cited Researchers, and 621 MDPI Editorial Board Members were included among the most influential scientific contributors over the past decade!
The 621 editors come from 33 countries, representing 21 scientific disciplines, and account for nearly one in every ten Highly Cited Researchers globally. This recognition speaks to the depth of expertise across our Editorial Boards and the strength of the scientific communities that choose to collaborate with MDPI. It is important to note that while citation metrics are not in themselves a proxy for quality, they do offer one lens on sustained scientific influence.
“Our strength comes from the scientific communities who choose to work with us”
Why this is important
Having more than 600 editors recognized on this list highlights:
- The high level of expertise guiding peer review across our journals
- The global and disciplinary diversity within our Editorial Boards
- Our commitment to maintaining strong, knowledgeable, and engaged editorial oversight
Impactful science is of course shaped by broad, diverse research communities, and no single metric captures the full picture of research quality. However, this recognition does serve as meaningful, independent affirmation of the calibre of many editors who contribute to MDPI’s work.
A closer look at the recognition
Clarivate’s methodology highlights researchers whose publications rank in the top one per cent by citation count, reflecting consistent influence over the past decade. The process includes:
- Evaluation of c. 200,000 highly cited papers
- Removal of retracted publications
- Filtering of papers with unusually large authorship groups to focus on clear contributions
That so many of our editors meet these thresholds reflects the impact of the communities behind our journals.
What this means going forward
This recognition underlines the fact that our strength comes from the scientific communities who choose to work with us.
For authors, partners, and readers, it confirms that:
- MDPI journals benefit from editorial guidance grounded in active, high-impact research
- Our Editorial boards include leaders who are helping shape the future direction of their fields
- MDPI continues to attract experts who value openness, efficiency, and scientific integrity
For our internal teams, it is a reminder that the work we do every day (supporting editors, refining workflows, and improving systems) directly contributes to the trust placed in MDPI by researchers worldwide.
Thank you to all our editorial teams, publishing staff, and journal relationship specialists, and to everyone who collaborates with our Editorial Boards. Achievements like this are only possible because of your ongoing hard work, dedication, and collaboration.

From our first annual MDPI UK Summit in Manchester, bringing together over 30 Chief Editors and Editorial Board Members to discuss MDPI’s mission, achievements, and collaborations in the UK.
Inside MDPI

MDPI Launches the Michele Parrinello Award for Computational Physical Science
In case you missed it, in November, we announced the launch of the Michele Parrinello Award. This new biennial international award will recognize pioneering contributions in computational physical science. The award honours Michele Parrinello, one of the most influential scientists of the past half-century in atomistic simulations and computational materials research.
This award reflects MDPI’s long-standing commitment to recognizing scientific excellence, supporting foundational research, and inspiring the next generation of scholars across disciplines.
“Be confident that what you do is meaningful”
Honouring a transformative scientific legacy
Professor Parrinello’s work has fundamentally reshaped how scientists model matter at the atomic scale. Together with Roberto Car, he introduced ab initio molecular dynamics, widely known as the Car–Parrinello method, opening new pathways in electronic structure calculations and molecular simulations. His subsequent contributions, including the Parrinello–Rahman method and metadynamics, have become core tools across physics, chemistry, materials science, and increasingly biology.

“Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking, ‘What is going to happen to me?’ and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”
– Professor Michele Parrinello
A global, community-led award

The award committee is chaired by Xin-Gao Gong, Professor of Physics at Fudan University and academician of the Chinese Academy of Sciences.
The Institute for Computational Physical Sciences at Fudan University will serve as the supporting institute, reinforcing the award’s international and cross-cultural foundation.
Nominations for the first edition of the Michele Parrinello Award opened on 1 November 2025, with submissions accepted until March 2026. The award will recognize scientists whose work has advanced computational physical science across physics, chemistry, and materials research – fields increasingly central to energy, sustainability, advanced manufacturing, and technological innovation.
Why this matters for MDPI
The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which supports science as a driver of long-term societal progress.

Alongside other foundation-level honours, including the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award, this new prize builds on our role in supporting excellence across career stages and disciplines.
MDPI journals and programs continue to recognize researchers through Best Paper Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, and Outstanding Reviewer Awards. Together, these initiatives reflect a simple belief: strong scientific communities are built through recognition, trust, and sustained support.
As MDPI approaches its 30th anniversary, the launch of the Michele Parrinello Award highlights our commitment not only to publishing research but also to helping shape the future of science by celebrating those who expand its boundaries.
Coming Together for Science

KEMÖ Consortium (Austria) Extends Open Access Agreement with MDPI until 2027
I’m pleased to share that MDPI has renewed its Institutional Open Access Program (IOAP) agreement with the Austrian library consortium KEMÖ, extending our partnership through 2027.
The renewed agreement now includes 23 Austrian institutions, with the Medical University of Vienna and the University of Natural Resources and Life Sciences (BOKU) joining the partnership. Participating institutions benefit from APC discounts across MDPI’s more than 495 journals, with centralized funding options further reducing the administrative burden for researchers and libraries.
“This renewal reflects shared commitment to advancing Open Access publishing in Europe”
Austria continues to be an important and engaged research community for MDPI, with 525+ Austrian Editorial Board Members, eight Editors-in-Chief, and 15 Section Editors-in-Chief contributing to our journals.
This renewal reflects long-term trust and shared commitment to advancing Open Access publishing in Europe, and improves MDPI’s collaboration with national OA infrastructures such as the Open Access Monitor Austria. Such long-term agreements show how MDPI’s growth is increasingly built on institutional trust, collaboration, and shared commitment to Open Access.
A big thank-you to the IOAP team and everyone involved in supporting this partnership.
Closing Thoughts

Celebrating the Next Generation of Scholars: MDPI’s 2024 Best PhD Thesis Awards
One of the privileges of working in scholarly publishing is supporting the beginning of new scientific journeys. We recently announced the recipients of MDPI’s 2024 Best PhD Thesis Awards, recognizing some of the most promising emerging researchers across disciplines.
These awards do more than celebrate academic excellence. They reflect something deeper about our mission: supporting the next generation of authors and the future of Open Science.
Recognition of Excellence
This year, we made awards to 55 early-career researchers across seven fields:
- Biology and Life Sciences
- Chemistry and Materials Science
- Computer Science and Mathematics
- Engineering
- Environmental and Earth Sciences
- Medicine and Pharmacology
- Interdisciplinary ‘Other’ fields
For those of you who have completed a PhD, you’ll know first-hand that behind each number is a story of perseverance, curiosity, and sustained effort. These researchers represent institutions around the world, with thesis topics spanning:
- Brain–machine interfaces and neural engineering
- Sustainable materials and next-generation batteries
- Cancer genomics, tumour microenvironments, and immunotherapy
- AI-driven image analysis, robotics, and computational models
- Climate change monitoring and environmental risk assessment
- Regenerative medicine, biomaterials, and drug development
These dissertations are early signs of the scientific directions that will shape the coming decade.
“Our mission is about building a global community of authors”
Why this is important
Every year, millions of scholars begin their research careers with limited visibility and few platforms for sharing their work. By recognizing outstanding PhD theses, we elevate authors early in their academic journeys, build MDPI’s connection to the global research community, reinforce our commitment to quality and rigor, and highlight the depth and breadth of scholarship published across our portfolio (from biology to materials science to mathematics).

A foretaste of the future
These 55 awardees represent the next generation of researchers whose work will influence science, policy, and society in the years ahead. What we support today helps shape the scientific ecosystem of tomorrow. Our mission goes beyond publishing papers. It is about building a global community of authors who will define the next era of scientific discovery.
To explore more about MDPI Awards, including current and upcoming Best PhD Thesis Awards, please click here.
Thank you to the editors, reviewers, and teams across MDPI who make these awards possible each year.
Everything we achieved this year was made possible by the collective effort of our global teams and the trust placed in us by the scholarly community. Thank you again, and here’s to the successful continuation of our collaboration in 2026!
Chief Executive Officer
MDPI AG
23 December 2025
Meet Us at the 2026 Society For Biomaterials Annual Meeting & Exposition, 25–28 March 2026, Atlanta, USA
MDPI is excited to announce its participation as an exhibitor at the 2026 Society For Biomaterials Annual Meeting & Exposition (SFB 2026), taking place in Atlanta, USA, from 25 to 28 March 2026.
The Society For Biomaterials (SFB)’s Annual Meeting is the preeminent conference for biomaterials science. Each year, the Society provides a diverse program of sessions, panels, and workshops relating to special interest groups, specific topics, and important issues. The meeting is a welcoming community of academics, industry leaders, scientists, and students, networking and discussing the latest research and innovations in the field. The Annual Meeting provides an academic and social environment for connection and knowledge to be obtained by each individual.
The theme for the SFB 2026 Annual Meeting is Biomaterials at the Crossroads: Connecting Science, Industry, and Innovation. This is where the future of biomaterials unfolds!
The following MDPI journals will be presented at the conference:
- Bioengineering;
- Journal of Functional Biomaterials;
- Biomolecules;
- Journal of Pharmaceutical and BioTech Industry;
- Prosthesis;
- Materials;
- Future Pharmacology;
- Pharmaceutics;
- Biomedicines.
If you are attending this conference, please feel free to contact us. Our delegates look forward to meeting you in person at booth #401 and answering any questions that you may have. For more information about the conference, please visit the following link: https://meetings.biomaterials.org/.
11 December 2025
Universal Health Coverage Day—“Unaffordable Health Costs? We’re Sick of It!”, 12 December 2025
International Universal Health Coverage Day, observed annually on 12 December, is a global response to the rallying cry: “Unaffordable health costs? We’re sick of it!” This day confronts the stark reality that millions are excluded from essential care due to financial barriers and mobilizes the world to transform health systems from privileges into universal rights.
Aligned with this year’s theme and Sustainable Development Goal 3: Good Health and Well-Being, MDPI underscores that research is not an academic exercise—it is a vital tool for diagnosing system failures and prescribing equitable solutions. From health economics studies that expose catastrophic spending, to innovations in low-cost diagnostics and community-based insurance models, researchers are providing the evidence and innovations to turn public frustration into actionable policy.
Join us in observing International Universal Health Coverage Day and supporting efforts to turn the promise of health for all into a tangible reality.

![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |

“Trends, Challenges, and Socioeconomic Impacts of HIV in Bangladesh: A Data-Driven Analysis (2000–2024)”
by Awnon Bhowmik, Mahmudul Hasan, Mrinal Saha and Goutam Saha
Sexes 2025, 6(3), 34; https://doi.org/10.3390/sexes6030034
“Development and Metrological Characterization of Low-Cost Wearable Pulse Oximeter”
by Andrea Cataldo, Enrico Cataldo, Antonio Masciullo and Raissa Schiavoni
Bioengineering 2025, 12(3), 314; https://doi.org/10.3390/bioengineering12030314
“Consequences of Hospital Closures for the Health Insurance Industry in the United States”
by Rainer W. G. Gruessner
Hospitals 2025, 2(1), 2; https://doi.org/10.3390/hospitals2010002
“Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life”
by Urszula Religioni, Rocío Barrios-Rodríguez, Pilar Requena, Mariola Borowska and Janusz Ostrowski
Medicina 2025, 61(1), 153; https://doi.org/10.3390/medicina61010153
“Human Rights and Inclusion of Vulnerable Groups in Health and Well-Being Policy Documents Relevant to Children and Young People in Ireland”
by Megan Lambert and Joanne McVeigh
Int. J. Environ. Res. Public Health 2024, 21(9), 1252; https://doi.org/10.3390/ijerph21091252
“Multidimensional Impact of Dupilumab on Chronic Rhinosinusitis with Nasal Polyps: A Complete Health Technology Assessment of Clinical, Economic, and Non-Clinical Domains”
by Ignazio La Mantia, Giancarlo Ottaviano, Martina Ragusa, Matteo Trimarchi, Emanuela Foglia, Fabrizio Schettini, Daniele Bellavia and Elena Cantone
J. Pers. Med. 2024, 14(4), 347; https://doi.org/10.3390/jpm14040347
“Factors in Immigrant Children’s Use of Physician and Dentist Visits, Hospital Care, and Prescribed Medication in the United States”
by Tyrone C. Cheng and Celia C. Lo
Eur. J. Investig. Health Psychol. Educ. 2023, 13(10), 2251-2261; https://doi.org/10.3390/ejihpe13100159
“Cost Analysis of Magnetic Resonance Imaging and Computed Tomography in Cardiology: A Case Study of a University Hospital Complex in the Euro Region”
by Francisco Reyes-Santias, Carlos García-García, Beatriz Aibar-Guzmán, Ana García-Campos, Octavio Cordova-Arevalo, Margarita Mendoza-Pintos, Sergio Cinza-Sanjurjo, Manuel Portela-Romero, Pilar Mazón-Ramos and Jose Ramon Gonzalez-Juanatey
Healthcare 2023, 11(14), 2084; https://doi.org/10.3390/healthcare11142084
“Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer”
by Justin Smith, Justin Yu, Louisa G. Gordon and Madhavi Chilkuri
Curr. Oncol. 2023, 30(5), 4922-4935; https://doi.org/10.3390/curroncol30050371
“Disentangling the Cost of Orphan Drugs Marketed in the United States”
by Hana Althobaiti, Enrique Seoane-Vazquez, Lawrence M. Brown, Marc L. Fleming and Rosa Rodriguez-Monguio
Healthcare 2023, 11(4), 558; https://doi.org/10.3390/healthcare11040558
“3D Printing in LMICs: Functional Design for Upper Limb Prosthetics in Uganda”
by Ali Hussaini, Peter Kyberd, Benedict Mulindwa, Robert Ssekitoleko, William Keeble, Laurence Kenney and David Howard
Prosthesis 2023, 5(1), 130-147; https://doi.org/10.3390/prosthesis5010011

|
“Healthcare Economics, Management, and Innovation for Health Systems” |
“Healthcare and Healthcare Economics in an Aging World: Adapting to Demographic Change” |
|
“Health Economics in Oncology: Addressing Financial Toxicity, Value-Based Care, and Equity” |
|

![]() |
The 1st International Online Conference on Clinical Reports Organizer: MDPI and Reports Highlights
Click here to read the full list of papers. |
11 December 2025
Article Layout and Template Revised for Future Volumes
We are pleased to announce updates to our article template, aimed at improving the readability and visual appeal of our publications. The following updates will be applied to articles published in volumes in 2026, starting from 19 December 2025.
Left information bar:
- Updated the logo and URL for “Check for updates”;
- Removed the “Citation” section (Note: Citation details remain accessible via “Cite” in the online article version);
- Changed the link in “Copyright” to a hyperlink format.
Footer:
- Added a DOI link at the bottom-right corner of each page.
The updated template is now available for download from the Instructions for Authors page of each journal.
We hope that the new version of the template will provide users with better experience and make the process more convenient.
For any questions or suggestions, please contact our production team at production@mdpi.com.
4 December 2025
Interview with Dr. Kenneth Maiese—Author of a Highly Cited Paper in Bioengineering

Name: Kenneth Maiese, MD
Email: wntin75@yahoo.com
Article Title: “Cognitive Impairment in Multiple Sclerosis”
The following is an interview with Dr. Kenneth Maiese:
1. Can you tell me about your background and what your research areas are?
I was born and raised in New Jersey, United States, and was fortunate to be the Valedictorian of my high school class at Pennsauken High School. I then graduated from the University of Pennsylvania Summa Cum Laude with Distinction and was subsequently a Teagle Scholar, Grupe Scholar, and Joseph Collins Scholar at Weill Medical College of Cornell University. Thereafter, I trained as a physician-scientist at Cornell, the National Institutes of Health, and as a senior executive in Executive Leadership and Business Administration at the Harvard T.H. Chan School of Public Health and the Kellogg School of Management at Northwestern University. Through my training, I have gained extensive experience in academic medicine, healthcare delivery, business development, managed care, biotechnology, and drug development holding positions as member and advisor for the National Institutes of Health Biotechnology and Venture Capital Development, National Institutes of Health Innovation Network, Chief Scientific Officer, Chief Medical Officer, tenured Professor and Chairman and Physician-in-Chief of the Department of Neurology and Neurosciences of Rutgers University, Global Head of Translational Medicine and External Innovation, Board Member of the Cancer Institute of New Jersey, Steering Committee Member for the Foundation for the National Institutes of Health, tenured Professor in Neurology, Anatomy & Cell Biology, Molecular Medicine, the Barbara Ann Karmanos Cancer Institute, and the National Institute of Health Center at Wayne State University, and Founding Editor and Editor-in-Chief of multiple highly successful international journals. I maintain clinical and scientific expertise in multiple medical disciplines, regulatory policy, and drug commercialization. My work has elucidated a number of new avenues for the fruitful discovery of innovative strategies to treat neurodegenerative disease, cardiovascular disorders, metabolic dysfunction, and cancer and has led to the development of first-in-class pharmaceuticals. As a result, I am grateful for the awards that I have received that include the Hoechst Award for exceptional basic science work, as well as being named a Johnson & Johnson Distinguished Investigator, chosen as a Henrietta B. and Frederick H. Bugher Foundation Investigator, receiving the Albrecht Fleckenstein Memorial Award for Distinguished Achievement in Basic Research, elected to America's Top Physicians and The Best of U.S. Physicians, recipient of Albert Nelson Marquis Lifetime Achievement Award, elected as an America’s Health Insurance Plans (AHIP) Executive Leadership Fellow, recognized as an international highly impactful expert in cell death pathways and Alzheimer’s Disease, and my work has been recognized with the distinction of "High Impact Research and Potential Public Health Benefit" by the National Institutes of Health.
2. What made you decide to publish a Bioengineering article?
I decided to publish in Bioengineering because the journal has a broad scope for demonstrating new advancements in biology and medicine. The journal focuses on high-priority issues that involve biomolecular pathways, cellular, metabolic, and genetic pathways, nanotechnology, and translational engineering applications.
3. Was it important to you that the journal is open access?
Yes, having Bioengineering as an open access journal is extremely important. Open access publishing increases readership accessibility and advances the distribution of knowledge while developing current and future research collaborations.
4. What do you hope that readers will get from your paper?
I believe that the paper highlights a number of key concepts. It is important to realize that approximately three million individuals suffer from multiple sclerosis (MS) throughout the world. It is a severe demyelinating disease in the nervous system with increased prevalence over the last five decades, and only recently has MS also been recognized as a significant etiology of cognitive loss and dementia. Dementia has now become the 7th leading cause of death in the world. Loss of cognitive function in MS occurs in approximately sixty-five percent of individuals and can affect processing of information, attention, and memory recall in these patients, leading to severe disability.
5. What critical scientific or engineering problems did your research initially aim to address?
Multiple cellular mechanisms may lead to the onset and progression of MS, such as inflammatory mediators, demyelination and remyelination pathways, oxidative stress, blood–brain barrier impairment, viral antigens, and cellular metabolism dependent upon nicotinamide adenine dinucleotide (NAD+). Although disease-modifying therapy (DMT) can limit the rate of relapse in MS patients, it cannot prevent disease progression. In addition, early initiation of DMTs may slow the progression of brain volume loss, but cognitive disability may continue to progress. For these reasons, it is incumbent for us to develop new and innovative avenues for the investigation and treatment of MS. The paper brings to light a number of novel pathways that involve autophagy, apoptosis, mammalian forkhead transcription factors (FoxOs), the mechanistic target of rapamycin (mTOR), AMP activated protein kinase (AMPK), the silent mating type information regulation 2 homolog 1 (Saccharomyces cerevisiae) (SIRT1), and associated pathways with the apolipoprotein E (APOE-ε4) gene and severe acute respiratory syndrome coronavirus (SARS-CoV-2) to offer promise for the understanding and treatment of cognitive loss in MS.
6. Are there follow-up studies planned based on this paper’s findings?
Additional future investigations will be necessary to further understand the complexity of autophagy, apoptosis, FoxOs, mTOR, AMPK, SIRT1, APOE-ε4 gene, and SARS-CoV-2 pathways since they are intimately connected, can have complementary as well as inverse relationships, and can affect multiple biological pathways such as cerebral blood flow, inflammation, stem cell survival, and glucose homeostasis.
7. Why do you think this article has been highly cited?
I believe two factors may be important for the high interest in the paper. First, the developing clinical recognition that MS is not just a disease of the sensory and motor systems of the nervous system, but MS is also a severe disorder that progressively affects cognitive function, and this dementia ultimately leads to additional disability and eventual demise in these MS patients. Second, although multiple underlying cellular pathways may lead to the onset and progression of MS such as inflammatory pathways, it is also becoming evident that the complexity of the pathology can lead to MS and the requirement for the elucidation and understanding of critical novel pathways can play a role in understanding and treating demyelinating disease for the development of new DMTs.
8. How is AI reshaping bioengineering research in disruptive ways?
Artificial Intelligence (AI) and Machine Learning models can be disruptive but offer the potential for highly positive results especially for the field of bioengineering. AI can be used to synthesize enormous data sets that can be heterogeneous in nature, such as involving genetic and proteomic data that involve multiple cellular pathways. Such large and diffuse data sets can present a challenge for traditional statistical methods, but AI and Machine Learning models can assimilate multiple pieces of multiparametric information that is nonhomogeneous to produce predicative signatures for underlying cellular pathways that in the long run can be translated into information that can be applied to the comprehension of clinical biology and treatments for patients.












































